Evaluation of initial heparin infusion rates for a high-dose protocol

Area of Science:

• Pharmacology
• Clinical Medicine
• Thrombosis Research

Background:

• Unfractionated heparin is a critical anticoagulant for thrombotic disease.
• Current weight-based dosing protocols, including an 80 U/kg loading dose and 18 U/kg/h infusion, can lead to variable and sometimes supratherapeutic activated partial thromboplastin time (aPTT).

Purpose of the Study:

• To compare the efficacy of an initial unfractionated heparin infusion rate of 14 U/kg/h versus 18 U/kg/h in achieving therapeutic anticoagulation.
• To assess the time required to reach therapeutic aPTT levels with different initial heparin infusion rates.

Main Methods:

• Retrospective chart review of 129 hospitalized patients receiving high-dose unfractionated heparin.
• Patients received either a 14 U/kg/h or 18 U/kg/h initial infusion rate.
• Activated partial thromboplastin time (aPTT) levels were monitored, and time to therapeutic anticoagulation was analyzed using a multivariable generalized linear model.

Main Results:

• Patients receiving 18 U/kg/h experienced initially elevated aPTT values.
• The 18 U/kg/h group took significantly longer (1.41 times) to reach therapeutic aPTT compared to the 14 U/kg/h group (estimate = 0.34, 95% CI 0.11, 0.57; p < 0.01).
• Higher body mass index was associated with increased time to achieve therapeutic anticoagulation.

Conclusions:

• An initial unfractionated heparin infusion rate of 14 U/kg/h appears more effective in achieving therapeutic anticoagulation faster than 18 U/kg/h.
• Reducing the time to therapeutic aPTT may decrease monitoring workload and dose titration frequency.
• Optimizing initial heparin infusion rates could improve patient outcomes and resource utilization in thrombotic disease management.